Albemarle sells controlling stake in Ketjen to KPS; expects $660M total cash proceeds

ALBEMARLE CORP

Albemarle will sell 51% of Ketjen to KPS for ~$536M cash + 49% rollover equity; total proceeds ~$660M including Eurecat sale.
Ketjen's Eurecat stake sold to Axens for €105M (~$125M); Ketjen retains collaboration with Eurecat.
Both transactions expected to close in first half 2026, subject to regulatory approvals and HSR clearance.
Albemarle records a non-cash goodwill impairment charge of $181.5M in Q3 2025 for Refining Solutions.
Proceeds to be used for debt reduction and general corporate purposes; Albemarle retains PCS business.

item 1.01 item 8.01 item 2.06 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.